InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
MIAMI, March 09, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard
A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD’s corporate website. Interested participants are encouraged to register more than 15 minutes before the start of the call.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit our official site.
Investor Contact:
Webb Campbell
Gilmartin Group LLC
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gold’s lost haven allure to swing back into view on deficit woes
Adeia Names Dipti Vachani Chief Executive Officer
ON Semiconductor Sees 4Q Adj EPS 95c-Adj EPS $1.07 >ON
-- Earnings Flash (CRGY) Crescent Energy Posts Q3 Revenue $1.35B vs. FactSet Est of $1.24B
Crypto prices
More
